X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1402) 1402
Newsletter (34) 34
Publication (31) 31
Book Review (20) 20
Magazine Article (13) 13
Newspaper Article (9) 9
Book Chapter (8) 8
Dissertation (3) 3
Trade Publication Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pergolide (943) 943
humans (740) 740
male (625) 625
female (461) 461
parkinson disease - drug therapy (395) 395
animals (374) 374
clinical neurology (367) 367
middle aged (336) 336
aged (288) 288
parkinson's disease (278) 278
pergolide - therapeutic use (272) 272
rats (243) 243
dopamine agonists - therapeutic use (240) 240
neurosciences (211) 211
adult (210) 210
bromocriptine (201) 201
pergolide - adverse effects (198) 198
pharmacology & pharmacy (193) 193
pergolide - pharmacology (192) 192
antiparkinson agents - therapeutic use (191) 191
dopamine agonists - adverse effects (181) 181
dopamine agonists (174) 174
pramipexole (167) 167
antiparkinson agents - adverse effects (147) 147
dopamine (146) 146
levodopa - therapeutic use (142) 142
parkinsons-disease (142) 142
index medicus (139) 139
dose-response relationship, drug (138) 138
ergolines - pharmacology (137) 137
ergolines - therapeutic use (135) 135
double-blind (130) 130
levodopa (130) 130
receptors, dopamine - drug effects (111) 111
cabergoline (108) 108
pergolide - administration & dosage (108) 108
rats, inbred strains (108) 108
dopamine agonists - pharmacology (104) 104
bromocriptine - therapeutic use (102) 102
drug therapy, combination (100) 100
ropinirole (98) 98
psychiatry (96) 96
therapy (96) 96
treatment outcome (90) 90
double-blind method (89) 89
ergolines - adverse effects (89) 89
dopamine agonist (80) 80
l-dopa (80) 80
restless legs syndrome (80) 80
dopamine agonists - administration & dosage (78) 78
time factors (78) 78
dopamine - metabolism (77) 77
risk factors (75) 75
heart valve diseases - chemically induced (71) 71
drug therapy (70) 70
restless legs syndrome - drug therapy (70) 70
bromocriptine - pharmacology (69) 69
levodopa - adverse effects (67) 67
sleep (67) 67
medicine, general & internal (63) 63
parkinson disease - physiopathology (60) 60
prolactin - blood (55) 55
antiparkinson agents - administration & dosage (54) 54
apomorphine (54) 54
apomorphine - pharmacology (54) 54
severity of illness index (53) 53
antiparkinson agents - pharmacology (52) 52
benzothiazoles (52) 52
corpus striatum - drug effects (52) 52
levodopa - administration & dosage (52) 52
placebo (52) 52
valvular heart-disease (52) 52
corpus striatum - metabolism (51) 51
aged, 80 and over (50) 50
parkinson disease - complications (50) 50
care and treatment (49) 49
agonists (48) 48
motor activity - drug effects (48) 48
nervous system agents (48) 48
disease (47) 47
receptors (47) 47
drug administration schedule (46) 46
receptors, dopamine - metabolism (46) 46
drugs (45) 45
veterinary sciences (45) 45
bromocriptine - adverse effects (44) 44
indoles - therapeutic use (44) 44
medicine & public health (44) 44
fenfluramine (43) 43
horses (42) 42
mice (42) 42
motor fluctuations (42) 42
rats, sprague-dawley (42) 42
diagnosis (41) 41
parkinsons disease (41) 41
valvulopathy (41) 41
ergolines - administration & dosage (40) 40
pergolide, adverse reactions (40) 40
adolescent (39) 39
follow-up studies (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1352) 1352
German (30) 30
French (29) 29
Spanish (17) 17
Japanese (10) 10
Czech (6) 6
Polish (5) 5
Dutch (4) 4
Chinese (3) 3
Danish (3) 3
Italian (3) 3
Russian (3) 3
Slovak (2) 2
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement Disorders, ISSN 0885-3185, 06/2004, Volume 19, Issue 6, pp. 656 - 662
Journal Article
Journal Article
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 11/2010, Volume 128, Issue 2, pp. 229 - 273
Though l-3,4-dihydroxyphenylalanine (L-DOPA) is universally employed for alleviation of motor dysfunction in Parkinson's disease (PD), it is poorly-effective... 
Ropinirole | Pergolide | receptor | Antiparkinson | Adrenoceptor | Pramipexole
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2007, Volume 6, Issue 9, pp. 826 - 829
Summary Background Retroperitoneal and pleuropulmonary fibrosis are well known but rare complications of the treatment of Parkinson's disease with ergolinic... 
Neurology | FIBROSIS | DRUG | PERGOLIDE | REGURGITATION | CABERGOLINE | CARDIAC VALVULOPATHY | FENFLURAMINE | 5-HT2B RECEPTORS | CLINICAL NEUROLOGY | Heart Valve Diseases - chemically induced | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Ergolines - adverse effects | Pergolide - adverse effects | Humans | Drug therapy | Parkinson's disease
Journal Article
Equine Veterinary Journal, ISSN 0425-1644, 09/2013, Volume 45, Issue S44, pp. 19 - 19
Aims Pergolide mesylate is the treatment of choice for equine pituitary pars intermedia dysfunction (PPID) and veterinary preparations are now licensed for... 
Nervous system agents | Pergolide
Journal Article
Drug Safety, ISSN 0114-5916, 4/2011, Volume 34, Issue 4, pp. 329 - 338
Background: Use of the ergot-derived dopamine receptor agonists (cabergoline and pergolide) is associated with an increased risk of cardiac valvulopathy.... 
Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Prescribing | Cabergoline, general | Legislation | Pergolide, general | Valvular-heart- disorders, drug-induced | Dopamine-receptor-agonists, general | Postmarketing-surveillance | VALVE REGURGITATION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MANAGEMENT | PERGOLIDE | CISAPRIDE | VALVULAR HEART-DISEASE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PREVALENCE | PARKINSONS-DISEASE | Ergolines - administration & dosage | Insurance Claim Review - statistics & numerical data | Legislation, Drug | Humans | Japan | Dopamine Agonists - therapeutic use | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Ergolines - adverse effects | Pergolide - adverse effects | Pergolide - administration & dosage | Pergolide - therapeutic use | Ergolines - therapeutic use | Regression Analysis | Drug Prescriptions - statistics & numerical data | Heart Valve Diseases - epidemiology | Dopamine Agonists - administration & dosage | Ultrasonography | Government Regulation | Heart Valve Diseases - chemically induced | Databases, Factual | Drug Utilization Review - statistics & numerical data | Heart Valve Diseases - diagnostic imaging | Physician and patient | Psychological aspects | Usage | Parkinson's disease | Dopamine | Agonists | Research | Drug therapy | Health aspects | Risk factors
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 06/2014, Volume 94, pp. 54 - 57
Journal Article